Teva Pharma News

Teva wants to expand Copaxone patent lawsuit

Ynetnews - 54 minutes ago
AP Teva Pharmaceutical Industries Ltd. said Tuesday it plans to expand a suit against Momenta Pharmaceuticals Inc. and Sandoz Inc., which are hoping to market a generic version of Teva's multiple ...

Cephalon, Inc. And Teva Pharmaceuticals Industries Limited's Barr Settle Patent Infringement Suit-Reuters

Reuters Key Development - 12 hours ago

Generics firms call Big Pharma anticompetitive

Sanofi, Teva among Ratiopharm bidders

FiercePharma - 35 minutes ago
No wonder Ratiopharm's owner family was so pleased by the first round of buyout bids. If Bloomberg's sources are correct, a smorgasbord of offers came in from financial investors, branded ...

Teva files amended complaint against Momenta and Sandoz

American Chronicle - 8 minutes ago
Teva Pharmaceutical Industries, an Israeli pharmaceutical company, has reported that it is seeking to amend its existing complaint against Momenta Pharmaceuticals and Sandoz to include patent ...

Teva Gets Court Decision Regarding Generic Prevacid SoluTab

Trading Markets - 4 minutes ago
Nov 12, 2009 (Close-Up Media via COMTEX) -- TEVA -- Teva Pharmaceutical Industries announced that the US District Court for the District of Delaware has issued a decision in its litigation over ...

Would Israel sacrifice Teva?

Ha'aretz - 15 minutes ago
By Ora Coren Will the Israeli government prefer to protect the interests of Teva Pharmaceutical Industries or sacrifice these interests on the alter of the OECD? A document from the OECD Trade ...

Ratiopharm Attracts At Least 10 First Round Bids Including Teva Pharmaceutical Industries Ltd.-Reuters

Reuters Key Development - 4 hours ago

New Report Just Published Teva Pharmaceutical Industries Ltd - Detailed Product Pipeline

Teva Sues Mylan to Protect Generic MS Drug

FDA news - 24 minutes ago
Teva Pharmaceutical Industries has filed a patent infringement suit against Mylan Pharmaceuticals and Natco Pharma to stop sales of a proposed generic version of the multiple sclerosis (MS) drug ...